BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Matrix Laboratories Limited 

1-1-151/1, 4th Floor
Sai Ram Towers
Alexander Road

Secunderabad    500 003  India
Phone: 91-40-27700363 or 91-40-55327722 Fax: 91-40-27700343


SEARCH JOBS




Industry
Pharmaceutical

Segment
Research





 Company News
Matrix Laboratories Limited (MAXL.BO) Completes Name Change to Mylan Laboratories Inc. (MYL) 10/19/2011 11:35:30 AM
Mylan Inc. (MYL)'s Matrix Laboratories Limited (MAXL.BO) Gets Tentative FDA Approval for AIDS Drug 9/20/2011 6:55:57 AM
Mylan Inc. (MYL)'s Matrix Laboratories Limited (MAXL.BO) Receives Approval for Generic Version of Aricept(R) Tablets 6/7/2011 11:34:39 AM
Mylan Inc. (MYL) to Rebrand Matrix Laboratories Limited (MAXL.BO) 5/27/2011 6:37:43 AM
Mylan Inc. (MYL)'s Matrix Laboratories Limited (MAXL.BO) Receives FDA Approval Under PEPFAR for Zidovudine Tablets, 100 mg 3/10/2011 6:51:27 AM
Mylan Inc. (MYL)'s Matrix Laboratories Limited (MAXL.BO) Receives Approval for Generic Version of Neurontin(R) Capsules 2/28/2011 10:00:45 AM
Tibotec Pharmaceuticals Ltd Signs Multiple Agreements With Generic Manufacturers, Including Mylan Inc. (MYL)'s Matrix Laboratories Limited (MAXL.BO), Aspen Pharmacare Holdings and Hetero Drugs to Provide Access to New HIV Treatment 1/27/2011 8:00:52 AM
Another Gastroesophageal Reflux Disease Drug Goes Generic by Matrix Laboratories Limited (MAXL.BO) 1/26/2011 6:21:00 AM
Mylan Inc. (MYL)'s Matrix Laboratories Limited (MAXL.BO) Receives Tentative FDA Approval Under PEPFAR for Lamivudine and Zidovudine Tablets, 30 mg/60 mg 1/20/2011 7:17:10 AM
Mylan Inc. (MYL) Receives Tentative FDA Approval Under PEPFAR for Matrix Laboratories Limited (MAXL.BO)' New Drug Application (NDA) for Efavirenz Tablets 12/22/2009 7:04:11 AM
123